Most just lately, it's been determined that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds into a wide array of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and does not activate a 2nd mess